Molecular targeted therapy for carcinoid and islet-cell carcinoma
- 31 March 2007
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Endocrinology & Metabolism
- Vol. 21 (1) , 163-172
- https://doi.org/10.1016/j.beem.2007.01.006
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Genome-Wide Analysis of Menin Binding Provides Insights into MEN1 TumorigenesisPLoS Genetics, 2006
- Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomasLaboratory Investigation, 2005
- Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumorsLaboratory Investigation, 2005
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Mutation and Expression Analyses Reveal Differential Subcellular Compartmentalization of PTEN in Endocrine Pancreatic Tumors Compared to Normal Islet CellsThe American Journal of Pathology, 2000
- Antitumor Effect of a Neutralizing Antibody to Vascular Endothelial Growth Factor on Liver Metastasis of Endocrine NeoplasmJapanese Journal of Cancer Research, 1998
- Carcinoid diseaseDiseases of the Colon & Rectum, 1997
- Immunohistochemical Expression of Transforming Growth Factor Alpha and Epidermal Growth Factor Receptor in Gastrointestinal CarcinoidsThe American Journal of Surgical Pathology, 1997
- Ampullary somatostatinoma associated with von Recklinghausen's neurofibromatosis presenting as obstructive jaundiceEuropean Journal of Surgical Oncology, 1996
- Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumoursInternational Journal of Cancer, 1995